Treatment of Aging Signs of the Skin With Bipolar Radiofrequency
Retrospective Data Collection to Evaluate the Safety and Performance of Accent System / BiPolarRF for the Treatment of Approved Indications Data Collection Protocol
1 other identifier
observational
150
1 country
1
Brief Summary
This is a retrospective data collection from patients treated with the bipolar radiofrequency applicator (Coaxipolar) of the Accent devices. Patient files were screened for suitable candidates providing before and after treatment pictures for blinded evaluation. The safety and efficacy of bipolar RF technology, both as a standalone treatment and in combination with unipolar RF, for facial contouring and the reduction of wrinkles and fine lines is investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedFirst Submitted
Initial submission to the registry
July 21, 2026
CompletedFirst Posted
Study publicly available on registry
July 31, 2026
CompletedJuly 31, 2026
July 1, 2025
2 months
July 21, 2026
July 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
GAIS
Skin laxity was assessed using the Global Aesthetic Improvement Scale (GAIS; 0-4 scale), GAIS 5-point scale (0 = worse, 1 = no change, 2 = mild improvement, 3 = much improvement, 4 = very much improvement)
From enrollment to the end of treatment at 24 weeks
Secondary Outcomes (3)
Fitzpatrick-wrinkle-scale
From enrollment to the end of treatment at 24 weeks
VISIA Score Change (if applicable)
From enrollment to the end of treatment at 24 weeks
Patient satisfaction (if applicable)
From enrollment to the end of treatment at 24 weeks
Eligibility Criteria
A total of up to 150 adult subjects of both genders and all skin types are to be included if they meet all of the inclusion and none of the exclusion criteria. Investigator is collecting data retrospectively from their respective patient pool.
You may qualify if:
- Healthy male or female ≥18 years old.
- Complete Medical History records are available
- Documented baseline and follow-up digital images are available
- Treatment with one applicator only for the approved indication for bipolar applicator such as skin laxity, wrinkles and rhytids
- provided consent for before and after (B\&A) pictures for evaluation Fitzpatrick skin type I- VI
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Estethica Clinic
Pristina, 10000, Kosovo
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 21, 2026
First Posted
July 31, 2026
Study Start
July 5, 2025
Primary Completion
August 30, 2025
Study Completion
December 30, 2025
Last Updated
July 31, 2026
Record last verified: 2025-07